Seattle Genetics

Clay B. Siegall, Ph.D. — President and Chief Executive Officer
Eric L. Dobmeier — Chief Operating Officer
Thomas C. Reynolds, M.D., Ph.D. — Chief Medical Officer
Todd E. Simpson — Chief Financial Officer
Vaughn B. Himes, Ph.D. — Executive VP, Process Sciences and Technical Operations
Chris Boerner, Ph.D. — Senior VP, Commercial
Jonathan Drachman, M.D. — Senior VP, Research and Translational Medicine
Christopher Pawlowicz — Senior VP, Human Resources
Elaine Waller, Pharm.D. — Senior VP, Regulatory Affairs
James Kyle Bryan, M.D. — VP, Medical Affairs
Jorge Cerda — VP, Information Technology
Darren Cline — VP, Marketing, Managed Markets and Reimbursement
Natasha Hernday — VP, Corporate Development
Charles R. Romp — VP, Sales
Kirk D. Schumacher — VP, Legal Affairs & Compliance and General Counsel
Peter D. Senter, Ph.D. — VP, Chemistry and Distinguished Fellow
Eric Sievers, M.D. — VP, Clinical Affairs
Charles Smith — VP, Quality
Samuel Yonren, M.D. — VP, Drug Safety